← Back to Search

Light Therapy

SunRay Light Boxes for Parkinson's Disease

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial will study the effects of different doses of light therapy on sleep in people with Parkinson's Disease.

Eligible Conditions
  • Parkinson's Disease
  • Sleep Disorders
  • Fatigue

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PDSS-2
Secondary outcome measures
PFS-16

Trial Design

4Treatment groups
Experimental Treatment
Group I: DRLT twice dailyExperimental Treatment1 Intervention
Participants in this arm will receive dim red light twice daily (morning and evening).
Group II: BWLT weeklyExperimental Treatment1 Intervention
Participants in this arm will receive bright white light therapy once weekly (in the evening).
Group III: BWLT twice dailyExperimental Treatment1 Intervention
Participants in this arm will receive bright white light therapy daily twice a day (morning and evening).
Group IV: BWLT once dailyExperimental Treatment1 Intervention
Participants in this arm will receive bright white light therapy daily once a day (in the evening)

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,932 Previous Clinical Trials
13,198,351 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers are engaged in this clinical experiment?

"This trial requires 144 individuals who pass the eligibility assessment to take part. Those wishing to participate can do so at a range of sites including University of California, Irvine in Irvine and University of Miami in Florida."

Answered by AI

Is this test available for enrollment at this time?

"Affirmative, clinicaltrials.gov indicates that this trial is currently in recruitment mode. It was initially posted on the 11th of September 2020 and subsequently updated on the 3rd of May 2021. This study necessitates 144 participants from 26 different sites."

Answered by AI

How many locations are involved in the implementation of this trial?

"Participants may join this medical trial at the University of California, Irvine in Irvine, CA, the University of Miami in Florida and Northwestern University situated in Chicago. There are a total of 29 sites across the USA accepting participants."

Answered by AI

Who else is applying?

What state do they live in?
Missouri
Other
California
North Carolina
How old are they?
18 - 65
65+
What site did they apply to?
Washington University in St. Louis
Other
UC Davis
Wake Forest University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1
0

Why did patients apply to this trial?

I am currently taking carbidopa levodopa, but am not sleeping well. I was Dx with ME/CFS 2 years ago. I have had high levels of fatigue since 2019.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

Would I have to discontinue taking levodopa, statin drugs, bp meds?
PatientReceived 2+ prior treatments

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Washington University in St. Louis: < 48 hours
  2. Wake Forest University: < 48 hours
Average response time
  • < 2 Days
~31 spots leftby Apr 2025